UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6
)*
Inhibitex,
Inc.
Common Stock, $0.001 par value
|
(Title of Class of Securities)
|
45719T103
Fati Sadeghi-Nejad, Esq.
General Counsel
QVT Financial LP
1177 Avenue of the
Americas, 9th Floor, New York, NY 10036
(212) 705-8888
copies to: Knute J. Salhus, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP
399 Park Avenue, New York, NY 10022
(212) 230-8800
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
November 18, 2008
|
(Date of Event which Requires Filing of this Statement)
|
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the
subject of this Schedule 13D, and is filing this schedule because of §§240.13d-l(e), 240.13d-l(f) or 240.13d-1(g), check the following box.
¨
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for
other parties to whom copies are to be sent.
*
|
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the
remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes)
CUSIP No. 45719T103
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).
QVT Financial LP
11-3694008
|
|
|
2.
|
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
¨
(b)
x
|
|
|
3.
|
|
SEC Use Only
|
|
|
4.
|
|
Source of Funds (See Instructions)
OO
|
|
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
6.
|
|
Citizenship or Place of Organization
Delaware
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7. Sole Voting Power
0
|
|
8. Shared Voting Power
2,318,507 shares of common stock
|
|
9. Sole Dispositive Power
0
|
|
10. Shared Dispositive Power
2,318,507 shares of common stock
|
|
|
|
|
|
11.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,318,507 shares of common stock
|
|
|
12.
|
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
13.
|
|
Percent of Class Represented by Amount in Row (11)
5.34%
|
|
|
14.
|
|
Type of Reporting Person (See Instructions)
PN
|
|
|
CUSIP No. 45719T103
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).
QVT Financial GP LLC
11-3694007
|
|
|
2.
|
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
¨
(b)
x
|
|
|
3.
|
|
SEC Use Only
|
|
|
4.
|
|
Source of Funds (See Instructions)
OO
|
|
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
6.
|
|
Citizenship or Place of Organization
Delaware
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7. Sole Voting Power
0
|
|
8. Shared Voting Power
2,318,507 shares of common stock
|
|
9. Sole Dispositive Power
0
|
|
10. Shared Dispositive Power
2,318,507 shares of common stock
|
|
|
|
|
|
11.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,318,507 shares of common stock
|
|
|
12.
|
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
13.
|
|
Percent of Class Represented by Amount in Row (11)
5.34%
|
|
|
14.
|
|
Type of Reporting Person (See Instructions)
OO
|
|
|
CUSIP No. 45719T103
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).
QVT Associates GP LLC
01-0798253
|
|
|
2.
|
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
¨
(b)
x
|
|
|
3.
|
|
SEC Use Only
|
|
|
4.
|
|
Source of Funds (See Instructions)
OO
|
|
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
6.
|
|
Citizenship or Place of Organization
Delaware
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7. Sole Voting Power
0
|
|
8. Shared Voting Power
2,318,507 shares of common stock
|
|
9. Sole Dispositive Power
0
|
|
10. Shared Dispositive Power
2,318,507 shares of common stock
|
|
|
|
|
|
11.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,318,507 shares of common stock
|
|
|
12.
|
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
13.
|
|
Percent of Class Represented by Amount in Row (11)
5.34%
|
|
|
14.
|
|
Type of Reporting Person (See Instructions)
OO
|
|
|
This Amendment No. 6 amends and supplements the Amendment No. 5 to the Schedule 13D filed by
QVT Financial LP (QVT Financial), QVT Financial GP LLC, QVT Fund LP (the Fund) and QVT Associates GP LLC on November 16, 2007 (the Schedule 13D), relating to the common stock, $0.001 par value per share (the
Common Stock) of Inhibitex, Inc. (the Issuer) held by the Fund, Quintessence Fund L.P. (Quintessence) and a separate discretionary account managed by QVT Financial for Deutsche Bank AG (the Separate
Account). Except as expressly stated herein, there have been no material changes in the information set forth in the Schedule 13D.
Item 2.
|
Identity and Background
|
(a) (c). This Schedule 13D is filed
by QVT Financial, a Delaware limited partnership, its general partner, QVT Financial GP LLC, a Delaware limited liability company, and QVT Associates GP LLC, a Delaware limited liability company which is the general partner of the Fund and
Quintessence, Cayman Islands limited partnerships. The principal executive offices of QVT Financial, QVT Financial GP LLC and QVT Associates GP LLC are located at 1177 Avenue of the Americas, 9th Floor, New York, New York 10036. QVT Financials
principal business is investment management, and it acts as the investment manager for the Fund, Quintessence and their several feeder funds. QVT Financial has the power to direct the vote and disposition of the Common Stock held by each of the Fund
and Quintessence.
Daniel Gold, Lars Bader, Nicholas Brumm, Arthur Chu and Tracy Fu (the Covered Persons) are the managing
members of QVT Financial GP LLC and QVT Associates GP LLC. The business addresses and principal occupations of each of the Covered Persons are set forth in Appendix A attached hereto, which is incorporated herein by reference. The business address
of each Covered Person is also the address of the principal employer of such Covered Person. Each of the Covered Persons is a citizen of the United States.
(d) and (e). During the last five years, none of QVT Financial, QVT Financial GP LLC, QVT Associates GP LLC or any of the Covered Persons has (i) been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to federal or state securities laws or finding any violations with respect to such laws.
Item 5.
|
Interest in Securities of the Issuer
|
(a) and (b). The information
contained on the cover pages to this Schedule 13D is incorporated herein by reference. QVT Financial is the investment manager for the Fund, which beneficially owns 2,083,501 shares of Common Stock, and for Quintessence, which beneficially owns
235,006 shares of Common Stock. QVT Financial has the power to direct the vote and disposition of the Common Stock held by each of the Fund and Quintessence. Accordingly, QVT Financial may be deemed to be the beneficial owner of an aggregate amount
of 2,318,507 shares of Common Stock, consisting of the shares owned by the Fund and Quintessence.
QVT Financial GP LLC, as General Partner of QVT
Financial, may be deemed to beneficially own the same number of shares of Common Stock reported by QVT Financial.
QVT Associates GP LLC, as General
Partner of the Fund and Quintessence, may be deemed to be the beneficial owner of an aggregate amount of 2,318,507 shares of Common Stock, consisting of the shares owned by the Fund and Quintessence.
The Covered Persons, as managing members of QVT Financial GP LLC and QVT Associates GP LLC, may be deemed to beneficially own the same number of shares of Common Stock
reported by QVT Financial, QVT Financial GP LLC and QVT Associates GP LLC. Each of the Covered Persons expressly disclaims beneficial ownership of the Common Stock reported herein as beneficially owned by QVT Financial, QVT Financial GP LLC and QVT
Associates GP LLC.
Each of QVT Financial and QVT Financial GP LLC disclaims beneficial ownership of the shares of Common Stock owned by
the Fund and Quintessence. QVT Associates GP LLC disclaims beneficial ownership of the shares of Common Stock owned by the Fund and Quintessence, except to the extent of its pecuniary interest therein.
The percentage disclosed in Item 13 of the Cover Pages for each reporting person is calculated based upon 43,380,570
shares of Common Stock outstanding, which is the total number of shares outstanding as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2008, as filed with the Securities and Exchange
Commission on November 10, 2008.
(c) The reported share amounts for QVT Financial, QVT Financial GP LLC, and QVT Associates GP LLC reflect amounts as
of November 20, 2008. The Separate Account effected the following transactions in the Common Stock during the past 60 days:
|
|
|
The Separate Account sold 200 shares of Common Stock in the open market on October 31, 2008 at a price of $0.26 per share.
|
|
|
|
The Separate Account sold 8,700 shares of Common Stock in the open market on November 3, 2008 at a price of $0.25 per share.
|
|
|
|
The Separate Account sold 11,600 shares of Common Stock in the open market on November 4, 2008 at a price of $0.24 per share.
|
|
|
|
The Separate Account sold 30,800 shares of Common Stock in the open market on November 5, 2008 at a price of $0.24 per share.
|
|
|
|
The Separate Account sold 54,727 shares of Common Stock in the open market on November 6, 2008 at a price of $0.25 per share.
|
|
|
|
The Separate Account sold 204,170 shares of Common Stock in the open market on November 7, 2008 at a price of $0.24 per share.
|
|
|
|
The Separate Account sold 4,601 shares of Common Stock in the open market on November 10, 2008 at a price of $0.23 per share.
|
|
|
|
The Separate Account sold 1,400 shares of Common Stock in the open market on November 11, 2008 at a price of $0.22 per share.
|
|
|
|
The Separate Account sold 10,600 shares of Common Stock in the open market on November 12, 2008 at a price of $0.22 per share.
|
|
|
|
The Separate Account sold 2,850 shares of Common Stock in the open market on November 13, 2008 at a price of $0.20 per share.
|
|
|
|
The Separate Account sold 2,700 shares of Common Stock in the open market on November 14, 2008 at a price of $0.21 per share.
|
|
|
|
The Separate Account sold 22,300 shares of Common Stock in the open market on November 17, 2008 at a price of $0.21 per share.
|
|
|
|
The Separate Account sold 56,278 shares of Common Stock in the open market on November 18, 2008 at a price of $0.20 per share.
|
|
|
|
The Separate Account sold 3,500 shares of Common Stock in the open market on November 19, 2008 at a price of $0.21 per share.
|
(d) Not applicable.
Item 7.
|
Material to Be Filed as Exhibits
|
Exhibit 1 -
Agreement regarding Joint Filing of Schedule 13D
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: November 21, 2008
|
|
|
|
|
|
|
|
|
QVT FINANCIAL LP
|
|
|
|
QVT FINANCIAL GP LLC
|
|
|
|
|
By QVT Financial GP LLC,
its General Partner
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
Name:
|
|
Daniel Gold
|
|
|
|
Name:
|
|
Daniel Gold
|
Title:
|
|
Managing Member
|
|
|
|
Title:
|
|
Managing Member
|
|
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
Name:
|
|
Oren Eisner
|
|
|
|
Name:
|
|
Oren Eisner
|
Title:
|
|
Authorized Signatory
|
|
|
|
Title:
|
|
Authorized Signatory
|
|
|
|
|
QVT ASSOCIATES GP LLC
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
|
|
|
|
|
|
Name:
|
|
Daniel Gold
|
|
|
|
|
|
|
Title:
|
|
Managing Member
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
|
|
|
|
|
|
Name:
|
|
Oren Eisner
|
|
|
|
|
|
|
Title:
|
|
Authorized Signatory
|
|
|
|
|
|
|
Exhibit 1
Agreement of Joint Filing
Pursuant to 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned
persons hereby agree to file with the Securities and Exchange Commission the Statement on Schedule 13D (the Statement) to which this Agreement is attached as an exhibit, and agree that such Statement, as so filed, is filed on behalf of
each of them.
IN WITNESS WHEREOF, the undersigned have executed this Agreement.
Dated: November 21, 2008
|
|
|
|
|
|
|
|
|
QVT FINANCIAL LP
|
|
|
|
QVT FINANCIAL GP LLC
|
|
|
|
|
By QVT Financial GP LLC,
its General Partner
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
Name:
|
|
Daniel Gold
|
|
|
|
Name:
|
|
Daniel Gold
|
Title:
|
|
Managing Member
|
|
|
|
Title:
|
|
Managing Member
|
|
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
Name:
|
|
Oren Eisner
|
|
|
|
Name:
|
|
Oren Eisner
|
Title:
|
|
Authorized Signatory
|
|
|
|
Title:
|
|
Authorized Signatory
|
|
|
|
|
QVT ASSOCIATES GP LLC
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Daniel Gold
|
|
|
|
|
|
|
Name:
|
|
Daniel Gold
|
|
|
|
|
|
|
Title:
|
|
Managing Member
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Oren Eisner
|
|
|
|
|
|
|
Name:
|
|
Oren Eisner
|
|
|
|
|
|
|
Title:
|
|
Authorized Signatory
|
|
|
|
|
|
|
Appendix A
Covered Persons
|
|
|
|
|
Name of Covered Person
|
|
Principal Business Address
|
|
Principal Occupation
|
Daniel Gold
|
|
QVT Financial LP
1177 Avenue of the Americas, 9th Floor
New York, New York 10036
|
|
Investment Management
|
|
|
|
Lars Bader
|
|
QVT Financial LP
1177 Avenue of the Americas, 9th Floor
New York, New York 10036
|
|
Investment Management
|
|
|
|
Nicholas Brumm
|
|
QVT Financial LP
1177 Avenue of the Americas, 9th Floor
New York, New York 10036
|
|
Investment Management
|
|
|
|
Arthur Chu
|
|
QVT Financial LP
1177 Avenue of the Americas, 9th Floor
New York, New York 10036
|
|
Investment Management
|
|
|
|
Tracy Fu
|
|
QVT Financial LP
1177 Avenue of the Americas, 9th Floor
New York, New York 10036
|
|
Investment Management
|
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024